Keyphrases
Insulin Receptor Substrate 1 (IRS1)
100%
Type 2 Diabetic Patients
100%
Insulin Receptor Signaling
100%
Rosiglitazone
100%
Tyrosine Phosphorylation
85%
Insulin
57%
Plasma Free Fatty Acids
57%
Glucose Disposal
42%
Glycemic Control
42%
Fatty Acid Composition
42%
Total-body
28%
Oral Glucose Tolerance Test
28%
Receptor Tyrosine Kinase
28%
Insulin Receptor
28%
Activity Unit
28%
Thiazolidinediones
28%
Insulin Clamp
28%
Control Subjects
14%
Plasma Glucose
14%
Hemoglobin A1c (HbA1c)
14%
Stimulatory Effect
14%
Skeletal muscle
14%
Fasting Plasma Glucose
14%
Insulin Sensitivity
14%
Non-diabetic
14%
Age-matched
14%
Fat-free Mass
14%
Euglycemic
14%
Indirect Calorimetry
14%
Diabetic Subjects
14%
Type 2 Diabetic
14%
Free Fatty Acids
14%
Insulin Infusion
14%
Non-oxidative
14%
Muscle Biopsy
14%
Insulin Stimulation
14%
Vastus Lateralis muscle
14%
Control Sensitivity
14%
75-g Oral Glucose Tolerance Test
14%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Receptor Substrate 1
100%
Diabetes Mellitus
100%
Insulin Receptor
100%
Rosiglitazone
100%
Fatty Acid
71%
Thiazolidinedione
28%
Hemoglobin A1c
14%
Non Insulin Dependent Diabetes Mellitus
14%
Calorimetry
14%
Albendazole
14%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
100%
Rosiglitazone
100%
Tyrosine Phosphorylation
50%
Fatty Acid Blood Level
33%
Glucose Test
25%
Glucose Tolerance Test
25%
Glycemic Control
25%
Glucose Blood Level
16%
Thiazolidinedione
16%
Skeletal Muscle
8%
Insulin Sensitivity
8%
Free Fatty Acids
8%
Fat Free Mass
8%
Calorimetry
8%